Public Company News

BRI's Ultra Micro Holding Marks Three Years, Serving 176 Million Customers and 36.1 Million Borrowers

JAKARTA, Indonesia, Sept. 17, 2024 /PRNewswire/ -- Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) celebrates the third anniversary of Ultra Micro Holding (UMi), which has made significant progress in promoting financial inclusion and economic empowerment inIndonesia. Established on September 13,...

2024-09-17 22:09 4545

UNDP and IBM Launch New Tools to Forecast Energy Access and Model Energy Equity

* UNDP and IBM developed two new interactive models for UNDP's Data Futures Exchange 's GeoHub : the AI model Electricity Access Forecasting and the statistical geospatial model Clean Energy Equity Index. * The organizations collaborated ...

2024-09-17 22:00 1397

Datasea's New 5G AI Multimodal Agreements Have Already Generated $9.0 Million of 5G-AI Services

Agreements Boost Fiscal 2025 Revenue and Expand Datasea's 5G Application Market Positioning inChina BEIJING, Sept. 17, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based company focused on innovative high-tech acoustics and 5G-Artificial Intelligence ("A...

2024-09-17 21:45 1626

Frost & Sullivan Recognizes Keysight's Network Packet Brokers with 2024 New Product Innovation Award

Keysight delivers scalable, high-performance, and highly flexible network visibility solutions for efficient network monitoring, threat detection, analysis and response SAN ANTONIO, Sept. 17, 2024 /PRNewswire/ -- Frost & Sullivan recently analyzed the network visibility market and recognizedKeys...

2024-09-17 21:00 1295

SKF initiates a separation of its Automotive business

GOTHENBURG, Sweden, Sept. 17, 2024 /PRNewswire/ -- The Board of Directors of SKF has decided to initiate a separation of its Automotive business with the objective of a separate listing on Nasdaq Stockholm through a Lex Asea distribution to its shareholders. The intention is to list the Automotiv...

2024-09-17 18:27 1274

Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity

- ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R) agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity - ASC30 is two- to threefold more potent, in vitro, than orforglipron and stimulated significantly greater insulin secretion when comp...

2024-09-17 18:25 2160

Electrolux Group appoints new Head of Investor Relations & Sustainability Reporting

STOCKHOLM, Sept. 17, 2024 /PRNewswire/ -- Electrolux Group has appointed Ann-Sofi Jönsson as Head of Investor Relations and Sustainability Reporting as from latestFebruary 10, 2025. Ann-Sofi Jönsson is currently Head of Investor Relations, Group Risk Management and Sustainability at Munters Gro...

2024-09-17 18:23 1182

Subgroup Analysis from Pivotal WU-KONG1B Study Exhibits Robust Efficacy of Sunvozertinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Across Different Baseline Characteristics

Results of subgroup analysis from the pivotal WU-KONG1B study in relapsed or refractory NSCLC with EGFR exon20ins presented at ESMO 2024 * Sunvozertinib demonstrated promising anti-tumor efficacy, regardless of EGFR exon20ins region classification, race, region, baseline brain metastasis, prio...

2024-09-17 15:47 1857

Aker Horizons ASA: Lars P. Sørvaag Sperre appointed new CEO; Kristian Røkke proposed nominated as Chairman

FORNEBU, Norway, Sept. 17, 2024 /PRNewswire/ -- Aker Horizons ASA ("Aker Horizons") announced that its Board of Directors has appointed Lars P. Sørvaag Sperre as its Chief Executive Officer effective from1 October 2024. Mr. Sperre will succeed Kristian Røkke, whom Aker ASA ("Aker") will propose t...

2024-09-17 15:07 1224

Autoliv appoints Fabien Dumont as Executive Vice President & Chief Technology Officer

STOCKHOLM, Sept. 17, 2024 /PRNewswire/ --- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), the worldwide leader in automotive safety systems, appoints Fabien Dumont as Executive Vice President & Chief Technology Officer and a member of the Autoliv Executive Management Team. Fabien Dumont previously se...

2024-09-17 15:06 1085

Rising Cost-of-Living Pressures Make Return Policies Crucial for Retail Success, Reveals Manhattan Associates Study

SYDNEY, Sept. 17, 2024 /PRNewswire/ -- As cost-of-living pressures mount and the post-End of Financial Year (EOFY) period settles in, the Australian retail landscape is being reshaped by a critical factor: return policies. New research from Manhattan Associates Inc . (...

2024-09-17 12:38 4094

ServiceNow expands National AI skills commitment in partnership with Republic Polytechnic

Singapore tech workers could reclaim up to 14 hours a week with AI, according to new research SINGAPORE, Sept. 17, 2024 /PRNewswire/ -- ServiceNow (NYSE: NOW), the AI platform for business transformation, today announced a new National Academic Partnership with Republic Polytechnic - the younges...

2024-09-17 11:25 1816

Unveil the Magic of Fall with Suika Game's '[Autumn Version] Special Skin Pack'

TOKYO, Sept. 17, 2024 /PRNewswire/ -- Aladdin X Inc., a subsidiary of the award-winning projector and laser projector brandXGIMI , is celebrating the autumn with the global launch of the '[Autumn Version] Special Skin Expansion Pack' onSeptember 17th. This pack allows play...

2024-09-17 09:00 2125

Sinch Accelerates Adoption of Rich Communication Services (RCS) Business Messaging with RCS Upscale

Leading the Evolution of Customer Engagement with Secure, Interactive, and Branded Messaging Across Devices & Platforms ATLANTA and STOCKHOLM, Sept. 17, 2024 /PRNewswire/ -- Sinch (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communicati...

2024-09-17 02:51 3910

Harvard Business School examines DBS' AI strategy and implementation in its first case study focusing on AI in an Asian bank

Authored by Feng Zhu, HBS Professor of Business Administration, the case highlights the bank's use of AI and takeaways for companies navigating technological change SINGAPORE, Sept. 16, 2024 /PRNewswire/ -- Harvard Business School (HBS) has published a case study on DBS' strategy towards Artific...

2024-09-16 22:00 2222

Intelligent Living Application Group Inc. Regains Compliance with Nasdaq's Minimum Bid Price Rule

HONG KONG, Sept. 16, 2024 /PRNewswire/ -- Intelligent Living Application Group Inc. (NASDAQ:ILAG ) ("Intelligent Living"...

2024-09-16 21:00 4422

Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment

BEIJING, Sept. 16, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that Guangzhou Concord Cancer Center ("Guangzhou H...

2024-09-16 20:00 1979

Game-Changing Lidar OT128 from Hesai Unveiled at IAA Transportation, Accelerating Autonomous Vehicles' Commercial Deployment

HANNOVER, Germany, Sept. 16, 2024 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), the global leader in lidar technology, is launching its powerful new lidar solution OT128 atEurope's biggest commercial vehicle trade fair IAA Transportation inHannover (booth location: Hall 12, #C71). Hesai's OT12...

2024-09-16 20:00 1344

Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment

NANJING, China, Sept. 16, 2024 /PRNewswire/ -- Vazyme (688105.SH), a leading life science technology company, significantly contributed to groundbreaking research published in Science Magazine through its innovative products. The study, which focuses on how mutant IDH1 inhibition activates tumor ...

2024-09-16 19:00 1790

Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024

* In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs), ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an overall response rate (ORR) of 21.1% and a disease control rate (DCR) of 89.5%. * Data from the...

2024-09-16 18:00 2040
1 ... 60616263646566 ... 1605

Week's Top Stories